Chardan Capital Estimates Immuneering FY2025 Earnings
Immuneering Co. (NASDAQ:IMRX – Free Report) – Chardan Capital issued their FY2025 earnings per share estimates for Immuneering in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst G. Livshits anticipates that the company will post earnings of ($1.65) per share for the year. Chardan Capital has a “Buy” […]
Immuneering Co. (NASDAQ:IMRX – Free Report) – Chardan Capital issued their FY2025 earnings per share estimates for Immuneering in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst G. Livshits anticipates that the company will post earnings of ($1.65) per share for the year. Chardan Capital has a “Buy” […]
